PLx Pharma Inc.
PLXP · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -20.1% | -76.8% | 30.8% | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | -278.2% | -69.8% | 43.9% | 44% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -3,368.9% | -3,548.7% | -1,226.5% | 227.2% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -1,594.6% | -1,900.2% | -162% | 223.8% |
| EPS Diluted | -0.22 | -0.33 | -0.12 | 0.13 |
| % Growth | 33.3% | -175% | -192.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |